| 000 | 00755 a2200181 4500 | ||
|---|---|---|---|
| 005 | 20250517194807.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2040-6223 | ||
| 024 | 7 |
_a10.1177/2040622317735283 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRøder, Michael E | |
| 245 | 0 | 0 |
_aMajor adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential. _h[electronic resource] |
| 260 |
_bTherapeutic advances in chronic disease _cJan 2018 |
||
| 300 |
_a33-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 773 | 0 |
_tTherapeutic advances in chronic disease _gvol. 9 _gno. 1 _gp. 33-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/2040622317735283 _zAvailable from publisher's website |
| 999 |
_c27989968 _d27989968 |
||